Difluprednate
- Level
- Commodity
- Parent
- 51422300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422309This classification denotes a therapeutic glucocorticoid with the molecular formula C27H34F2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8A06QG2QE, chemically known as 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione (6alpha,11beta)- but generally known as difluprednate, which bears US NIH Compound Identifier 32037. European Medicines Agency schedules Difluprednate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07131MIG. The term DIFLUPREDNATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules difluprednate in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule difluprednate under HS 29372200 and SITC 54153. As of Q4 2014, DIFLUPREDNATE remains the US FDA Preferred Term for this commodity. Difluprednate bears US NLM identifiers UMLS ID C0058004 and NCI Concept Code C80259. SMILES: FC12C(C3C(C(OC(=O)CCC)(CC3)C(=O)COC(=O)C)(CC1O)C)CC(F)C1=CC(=O)C=CC21C.
Same parent
Under 51422300 · 70Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.